PEAK6 Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-19,300
Closed -$401K 4323
2017
Q4
$401K Sell
19,300
-77,400
-80% -$1.23M ﹤0.01% 2649
2017
Q3
$1.39M Buy
96,700
+40,300
+71% +$609K 0.01% 1681
2017
Q2
$976K Buy
56,400
+600
+1% +$7.19K 0.01% 1944
2017
Q1
$615K Sell
55,800
-20,100
-26% -$277K 0.01% 2080
2016
Q4
$1.1M Sell
75,900
-28,300
-27% -$519K 0.01% 1771
2016
Q3
$2.56M Sell
104,200
-5,300
-5% -$137K 0.02% 1108
2016
Q2
$2.21M Sell
109,500
-72,000
-40% -$2.04M 0.02% 1176
2016
Q1
$4.77M Sell
181,500
-261,800
-59% -$19.4M 0.04% 644
2015
Q4
$45.1M Buy
443,300
+83,000
+23% +$9.32M 0.3% 33
2015
Q3
$64.3M Buy
360,300
+251,700
+232% +$58.7M 0.34% 17
2015
Q2
$24.1M Sell
108,600
-34,600
-24% -$7.67M 0.14% 138
2015
Q1
$28.4M Buy
143,200
+3,100
+2% +$550K 0.22% 62
2014
Q4
$20.1M Buy
140,100
+20,300
+17% +$2.73M 0.15% 127
2014
Q3
$15.7M Buy
119,800
+1,700
+1% +$203K 0.12% 180
2014
Q2
$14.9M Buy
118,100
+34,200
+41% +$4.36M 0.14% 142
2014
Q1
$11.1M Buy
83,900
+14,300
+21% +$1.96M 0.09% 238
2013
Q4
$8.17M Sell
69,600
-19,400
-22% -$2.13M 0.06% 424
2013
Q3
$4.65M Buy
89,000
+33,500
+60% +$3.26M 0.03% 820
2013
Q2
$4.78K Buy
+55,500
New +$4.37M 0.02% 788

Other funds holding BHC

PEAK6 Group's BHC Position: Q4 2017 in Review

PEAK6 Group sold out of Bausch Health (BHC) in Q4 2017, closing a stake of 35,984 shares — an estimated $571K sold.

PEAK6 Group first reported a position in BHC in Q2 2013 and held it in 13 quarters. The position peaked at $20M in Q4 2013. 315 funds tracked by Wall St. Rank hold BHC as of Q4 2017.

  • PEAK6 Group reported no remaining Bausch Health position as of Q4 2017 after selling out during the quarter.
  • PEAK6 Group sold 35,984 Bausch Health shares in Q4 2017, an estimated $571K.
  • PEAK6 Group first reported a position in Bausch Health in Q2 2013 and held it in 13 quarters.
  • PEAK6 Group's Bausch Health position peaked at $20M in Q4 2013.
  • 315 funds tracked by Wall St. Rank held Bausch Health as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.